Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $1.38 Million - $1.75 Million
25,000 Added 62.5%
65,000 $3.65 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $2.29 Million - $2.79 Million
40,000 New
40,000 $2.41 Million
Q3 2021

Nov 15, 2021

SELL
$35.31 - $50.56 $3.71 Million - $5.31 Million
-105,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$25.8 - $41.09 $2.71 Million - $4.31 Million
105,000 New
105,000 $4.31 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.